<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04644679</url>
  </required_header>
  <id_info>
    <org_study_id>5767</org_study_id>
    <nct_id>NCT04644679</nct_id>
  </id_info>
  <brief_title>Monitoring Strategies for the Detection of Atrial Fibrillation in Patients With Cryptogenic Stroke</brief_title>
  <official_title>48-hour Versus 7-day Monitoring for the Detection of Atrial Fibrillation in Patients With Cryptogenic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Italiano de Buenos Aires</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Italiano de Buenos Aires</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized clinical trial comparing two monitoring strategies, the use of a 48-hour Holter&#xD;
      (routine care branch) and an event recorder for 7 days (intervention branch).&#xD;
&#xD;
      Patients admitted for cryptogenic stroke will be included. Enrollment and randomization of&#xD;
      patients will be carried out during the index case hospitalization, while follow-up will be&#xD;
      done on an outpatient basis until day 7.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Once the diagnose of cryptogenic stroke have been carried out, informed consent will be taken&#xD;
      and participants will be randomized to 48-hour monitoring arm or 7-day monitoring arm,&#xD;
      followed by discharge from hospital.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2, 2020</start_date>
  <completion_date type="Anticipated">October 19, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 12, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Atrial fibrillation</measure>
    <time_frame>7 days</time_frame>
    <description>Detection of one episode of atrial fibrillation or atrial flutter &gt;30 seconds up to 7 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Supraventricular arrhythmia</measure>
    <time_frame>7 days</time_frame>
    <description>Count of beats per day of non-sustained irregular atrial tachyarrhythmia or supraventricular extrasystoles up to 7 days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">530</enrollment>
  <condition>Stroke</condition>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>48-hr</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>48-hr electrocardiographic monitoring</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7-day</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>7-day electrocardiographic monitoring</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>7-day electrocardiographic monitoring</intervention_name>
    <description>7-day external electrocardiographic monitoring</description>
    <arm_group_label>7-day</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>48-hr electrocardiographic monitoring</intervention_name>
    <description>48-hr external electrocardiographic monitoring</description>
    <arm_group_label>48-hr</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients who have studies that classify stroke or TIA as cryptogenic and who can&#xD;
             carry out monitoring for 48 hours or 7 days will be included.&#xD;
&#xD;
          -  Age â‰¥ 18 years&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          -  History of atrial fibrillation (or atrial flutter) documented.&#xD;
&#xD;
          -  Patients who already have an event recorder in place, permanent pacemaker, or&#xD;
             implantable cardioverter-defibrillator&#xD;
&#xD;
          -  Evidence of lacunar infarction.&#xD;
&#xD;
          -  Hemorrhagic stroke&#xD;
&#xD;
          -  Patient for palliative care&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gustavo Maid, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Italiano de Buenos Aires</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rodrigo Aguirre</last_name>
    <phone>+54 11 4959 0200</phone>
    <phone_ext>5303</phone_ext>
    <email>rodrigo.aguirre@hospitalitaliano.org.ar</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Italiano de Buenos Aires</name>
      <address>
        <city>Buenos Aires</city>
        <state>C.a.b.a</state>
        <zip>C1199</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodrigo Aguirre</last_name>
      <phone>4959 0200</phone>
      <phone_ext>5303</phone_ext>
      <email>rodrigo.aguirre@hospitalitaliano.org.ar</email>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 30, 2020</study_first_submitted>
  <study_first_submitted_qc>November 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2020</study_first_posted>
  <last_update_submitted>November 19, 2020</last_update_submitted>
  <last_update_submitted_qc>November 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

